Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats

Gut

Volumn 43, Issue 6, 1998, Pages 783-790

  Barbier, M ^a   Cherbut, C ^b   Aube A C ^a   Blottiere H M ^b   Galmiche, J P ^a  

^a HÔTEL DIEU   (France)

^b INRA ^*

Author keywords

Anorexia; Endotoxic shock; Experimental rat intestinal inflammation; Inflammatory bowel disease; Leptin; Tumour necrosis factor

Indexed keywords

INDOMETACIN; INTERLEUKIN 1; LEPTIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BLOOD LEVEL; COLITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENERGY BALANCE; ENTERITIS; FOOD INTAKE; ILEITIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; WEIGHT REDUCTION;

EID: 0031768795     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.6.783     Document Type: Article

References (39)

1. Campfield LA, Smith FJ, Guisez Y, et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-9.
2. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-6.
3. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-71.
4. Ghilardi N, Ziegler S, Wiestner A, et al. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996;93:6231-5.
5. Löllmann B, Grüninger S, Stricker-Krongrad A, et al. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and e in different mouse tissues. Biochem Biophys Res Commun 1997;238:648-52.
6. Chehab FF, Mounzih K, Lu R, et al. Early onset of reproductive function in normal female mice treated with leptin. Science 1997;275:88-90.
7. Cioffi JA, Shafer AW, Zupancie TJ, et al. Novel B219 OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nat Med 1996;2:585-9.
8. Gainsford T, Willson TA, Metcalf D, et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl. Acad Sci USA 1996;93: 14564-8.
9. Madej T, Boguski MS, Bryant SH. Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett 1995;373:13-18.
10. Silk DBA, Payne-James J. Inflammatory bowel disease: nutritional implications and treatment. Proc Nutr Soc 1989; 48:355-61.
11. Rigaud D, Angel LA, Cerf M, et al. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr 1994;60:775-81.
12. Mingrone G, Greco AV, Benedetti G, et al. Increased resting lipid oxidation in Crohn's disease. Dig Dis Sci 1996;41:72-6.
13. Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996;97:2152-7.
14. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997;185:171-5.
15. Janik JE, Curti BD, Considine RV, et al. Interleukm 1α increases serum leptin concentrations in humans. J Clin Endocrinol Metab 1997;82:3084-6.
16. Zumbach MS, Boehme MWJ, Wahl P, et al. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997;82:4080-2.
17. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
18. Yamada T, Deitch E, Specian RD, et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993;17:641-62.
19. Uchida A, Yamada T, Hayakawa T, et al. Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation. Am J Physiol 1997;272: G1249-57.
20. Krawisz JE, Sharon P, Stenstin WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984;87:1344-50.
21. McHugh KJ, Collins SM, Weingarten HP. Central interleukin-1 receptors contribute to suppression of feeding after acute colitis in the rat. Am J Physiol 1994;266: R1659-63.
22. Martinolle JP, Garcia-Villar R, Fioramonti J, et al. Altered contractility of circular and longitudinal muscle in TNBS-inflamed guinea pig ileum. Am J Physiol 1997;272:G1258-67.
23. Rachmilewitz D, Simon PL, Schwartz LW, et al. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1980;97:326-37.
24. Weigle DS, Duell PB, Connor WE, et al. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol. Metab 1997;82:561-5.
25. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
26. O'Reilly B, Vander AJ, Kluger MJ. Effects of chronic-infusion of lipopolysaccharide on food intake and body weight temperature of the rat. Physiol Behav 1988;42:287-91.
27. Tateishi H, Mitsuyama K, Toyonaga A, et al. Role of cytokines in experimental colitis: relation to intestinal permeability. Digestion 1997;58:271-81.
28. Neilly PJD, Gardiner KR, Kirk SJ, et al. Endotoxaemia and cytokine production in experimental colitis. Br J Surg 1995;82:1479-82.
29. Mantzoros CS, Moschos S, Avramopoulos I, et al. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 1997;82:3408-13.
30. Ameho CK, Adjei AA, Hamsun EK, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulphonic acid induced colitis. Gut 1977;41:487-93.
31. Gershenwald JE, Fong Y, Fahey III TJ, et al. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 1990;87:4966-70.
32. Kirchgessner TG, Uysal T, Wiesbrock SM, et al. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Inves 1997;100:2777-82.
33. Granowitz, EV. Transforming growth factor-β enhances and pro-inflammatory cytokines inhibit OB gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1997; 240:382-5.
34. De Vos P, Saladin R, Auwerx J, et al. Induction of ob gene expression by corticosteroids is accomplished by body weight loss and reduced food intake. J Biol Chem 1995;270: 15958-61.
35. Papaspyrou-Rao S, Schneider SH, Petersen RN, et al. Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 1997;82:1635-7.
36. Hoppin AG, Kaplan LM, Leichtner AM, et al. Lepin over-expression does not mediate growth failure in children with inflammatory bowel disease [abstract]. Gastroenterology 1997;112:A880.
37. Klapproth JM, James SP, DeWoody KL, et al. Role of leptin in regulation of body mass in Crohn's disease [abstract]. Gastroenterology 1997;112:A1015.
38. Ballinger AB, Hallyburton EM, Besser R, et al. Serum leptin in inflammatory bowel disease (IBD): implications for the pathogenesis of anorexia and weight loss [abstract]. Gastroenterology 1997;112:A1130.
39. Dieleman LA, Pena AS, Meuwissen SGM, et al. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol 1997; 32(suppl 223):99-104.